Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval Post author:Sam Post published:August 20, 2020 Post category:Devices & Diagnostics Letter Mylan has launched the product in 120mg and 240mg delayed-release capsule forms. Source: Devices & Diagnostics Letter You Might Also Like FDA Warns Danish Drugmaker for Testing Failures March 24, 2020 Preceptis’ Ear Tube System Receives FDA Clearance June 22, 2020 First Genetic Test for Fragile X Syndrome Cleared February 24, 2020